← Open Payments lookup

COMFORT UCHE: Open Payments

NPI 1043817703 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,267 in 54 payments from 11 companies in 2025. Trend: 2023 $78 · 2024 $299 · 2025 $1,267

Food & beverage: $1,267
CompanyPaymentsAmount
Madrigal Pharmaceuticals25$583
Gilead Sciences, Inc.10$238
Eisai Inc.4$110
Intercept Pharmaceuticals, Inc.4$94
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$81
Ipsen Biopharmaceuticals, Inc2$44
ORPHALAN INC2$44
Amgen Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19
Novo Nordisk Inc1$17

Products named: REZDIFFRA, Lenvima, OCALIVA, XIFAXAN, IQIRVO, CUVRIOR, UPLIZNA, LIVTENCITY.

Industry payments across TX — which companies pay providers there.